These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31617063)

  • 1. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis and verification of molecular genetic targets for glioblastoma.
    Xue L; Liu H; Chen Y; Wei L; Hong J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.
    Luo X; Xu S; Zhong Y; Tu T; Xu Y; Li X; Wang B; Yang F
    Oncol Lett; 2019 Dec; 18(6):6171-6179. PubMed ID: 31788092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis.
    Jangholi E; Tehran HA; Ghasemi A; Hoseinian M; Firoozi S; Ghodsi SM; Tamaddon M; Bereimipour A; Hadjighassem M
    Cancer Rep (Hoboken); 2024 Jul; 7(7):e2080. PubMed ID: 38967113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.